1 , 6-8 As per clinical guidelines, initial therapeutic considerations should be lifestyle modification and statin therapy in those with borderline-intermediate or higher predicted risk
Explore GLP-1 medication options, the GLP-1 weight loss program, tirzepatide medication options, or the tirzepatide weight loss program
Gallez A, Dias Da Silva I, Wuidar V, Foidart JM, Pequeux C
Keywords: GLP1, obesity, adolescents, GLP1 dual agonist, GLP1 triple agonist, diabetes Introduction The Growing Burden of Adolescent Obesity With prevalence rates rising sharply over the past few decades, adolescent obesity has emerged as a major global public health challenge